Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.65 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.65 |
| ▸ | P2RY1 | P47900 | 8/20 | 0.64 |
| ▸ | P2RY2 | P41231 | 3/20 | 0.64 |
| ▸ | P2RX1 | P51575 | 2/20 | 0.64 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.64 |
| ▸ | SRC | P12931 | 1/20 | 0.64 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | KRAS | P01116 | 2/20 | 0.61 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.60 |
| ▸ | NT5E | P21589 | 1/20 | 0.60 |
| ▸ | MACROD2 | A1Z1Q3 | 1/20 | 0.60 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.60 |
| ▸ | MACROD1 | Q9BQ69 | 1/20 | 0.60 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.60 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.58 |
| ▸ | P2RY11 | Q96G91 | 2/20 | 0.58 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18661219 | 1.00 | TGM2 (0.65) | TGM2P2RX3P2RY1P2RY2P2RX1 | |
| SCHEMBL4362564 | 1.00 | TGM2 (0.65) | TGM2P2RX3P2RY1P2RY2P2RX1 | |
| Gtp SCHEMBL4368666 | 0.97 | TGM2 (0.62) | TGM2P2RX3P2RY1P2RY2P2RX1 | |
| Gtp SCHEMBL4362801 | 0.97 | TGM2 (0.62) | TGM2P2RX3P2RY1P2RY2P2RX1 | |
| Guanosine Triphosphate SCHEMBL44409 | 0.97 | TGM2 (0.62) | TGM2P2RX3P2RY1P2RY2P2RX1 | |
| Guanosine Triphosphate SCHEMBL4362831 | 0.97 | TGM2 (0.62) | TGM2P2RX3P2RY1P2RY2P2RX1 | |
| SCHEMBL2341432 | 0.96 | P2RY1 (0.62) | TGM2P2RX3P2RY1P2RY2P2RX1 | |
| Guanosine Triphosphate SCHEMBL20266272 | 0.96 | TGM2 (0.62) | TGM2P2RX3P2RY1P2RY2P2RX1 | |
| SCHEMBL31145699 | 0.95 | P2RY1 (0.61) | TGM2P2RX3P2RY1P2RY2P2RX1 | |
| SCHEMBL4366717 | 0.95 | TGM2 (0.62) | TGM2P2RX3P2RY1P2RY2P2RX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150366777-A1 | COMBINATION OF SKIN PROTECTION AGAINST DAMAGES CAUSED BY INFRARED RADIATION | HYPERMARCAS S.A. (BR) | 2015-12-24 | — | — | US | claimed |
| US-20260021027-A1 | POLYPEPTIDE COSMETIC COMPOSITIONS | ELC MANAGEMENT LLC (US) | 2026-01-22 | — | — | US | disclosed |
| CN-114795996-B | Composition containing nucleoside components and application thereof | 广东先强药业有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-114795996-A | Composition containing nucleoside components and application thereof | 广东先强药业有限公司 | 2022-07-29 | — | — | CN | disclosed |
| US-20150366777-A1 | COMBINATION OF SKIN PROTECTION AGAINST DAMAGES CAUSED BY INFRARED RADIATION | HYPERMARCAS S.A. (BR) | 2015-12-24 | — | — | US | disclosed |
| US-20090186358-A1 | Pathway Analysis of Cell Culture Phenotypes and Uses Thereof | WYETH (US) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260021027-A1 | POLYPEPTIDE COSMETIC COMPOSITIONS | CUTA, SPPL2B, SPPL2A | TGM2 177/4885P2RX3 2891/4885P2RY1 1799/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.